Expression profiles of selected circulating microRNAs (miR-192-5p and miR-155-3p) in NAFLD and their association with obesity and type 2 diabetes mellitus.
文献摘要
Background Non-alcoholic fatty liver disease (NAFLD) is a prevalent systemic metabolic disorder closely linked to obesity and type 2 diabetes mellitus (T2DM). Circulating microRNAs have emerged as potential biomarkers reflecting disease progression and metabolic risk. Objectives This study aimed to investigate the clinical, biochemical, and molecular profiles of NAFLD patients, focusing on miRNA-155-3p and miRNA-192-5p, and to evaluate their diagnostic and predictive value. Methods A total of 200 participants were enrolled: 50 healthy controls, 50 NAFLD, 50 NAFLD with obesity, and 50 NAFLD with T2DM. Clinical, biochemical (liver enzymes, lipid profile, HOMA-IR, CRP, 25(OH) vitamin D) and circulating miRNA levels were measured. Statistical analyses included Kruskal-Wallis tests, ROC curves, and univariate and multivariate multinomial logistic regression. Results NAFLD patients, particularly with obesity and T2DM, showed elevated BMI, SGPT/SGOT, cholesterol, TG, LDL, HOMA-IR, and CRP (p Conclusions Circulating miRNA-155-3p and miRNA-192-5p are potential molecular markers and risk predictors for NAFLD, linking metabolic dysregulation with hepatic pathology.